Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients.

Cancer Cell Int · 2018 · PMC6303841 · PMID 30598640

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

showed a trendp = 0.056so close (0.05 < p ≤ 0.1)

The older patient group also showed a trend of more DNMT3A (14.7% vs 5.4%, p = 0.056) and RUNX1 (11.8% vs 4.5%, p = 0.081) mutations than the younger patient group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.